DE69133067T2 - Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung - Google Patents

Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung

Info

Publication number
DE69133067T2
DE69133067T2 DE69133067T DE69133067T DE69133067T2 DE 69133067 T2 DE69133067 T2 DE 69133067T2 DE 69133067 T DE69133067 T DE 69133067T DE 69133067 T DE69133067 T DE 69133067T DE 69133067 T2 DE69133067 T2 DE 69133067T2
Authority
DE
Germany
Prior art keywords
cyclin
antibodies
human
human cyclin
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69133067T
Other languages
German (de)
English (en)
Other versions
DE69133067D1 (de
Inventor
Christian Brechot
Xavier Chenivesse
Berthold Henglein
Jian Wang
Frederique Zindy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE69133067D1 publication Critical patent/DE69133067D1/de
Application granted granted Critical
Publication of DE69133067T2 publication Critical patent/DE69133067T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69133067T 1990-02-12 1991-02-06 Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung Expired - Lifetime DE69133067T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9001596A FR2658204A1 (fr) 1990-02-12 1990-02-12 Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.
PCT/FR1991/000089 WO1991012324A1 (fr) 1990-02-12 1991-02-06 Nouvelles compositions de cycline a humaine et leur procede de production, sequence nucleotidique correspondante, procede et agents de detection ou de diagnostic de la proliferation cellulaire et procede et agents d'inhibition de la proliferation cellulaire

Publications (2)

Publication Number Publication Date
DE69133067D1 DE69133067D1 (de) 2002-08-22
DE69133067T2 true DE69133067T2 (de) 2003-05-08

Family

ID=9393594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69133067T Expired - Lifetime DE69133067T2 (de) 1990-02-12 1991-02-06 Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung

Country Status (7)

Country Link
US (2) US5849508A (https=)
EP (1) EP0471804B1 (https=)
AT (1) ATE220717T1 (https=)
DE (1) DE69133067T2 (https=)
ES (1) ES2181667T3 (https=)
FR (1) FR2658204A1 (https=)
WO (1) WO1991012324A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273386T1 (de) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res Menschliches cyclin e
FR2712301A1 (fr) * 1993-11-10 1995-05-19 Inst Nat Sante Rech Med Séquence nucléotidique du promoteur de la cycline A humaine et séquences anti-sens y relatives.
GB0123856D0 (en) * 2001-10-05 2001-11-28 Amersham Pharm Biotech Uk Ltd Method for determining cell cycle position
WO2004040314A1 (en) * 2002-10-31 2004-05-13 Chemometec A/S A method for assessment of particles
WO2006119435A2 (en) * 2005-05-04 2006-11-09 Invitrogen Corporation Identification of cancer biomarkers and phosphorylated proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
EP0321362B1 (en) * 1987-12-16 1996-09-25 Institut Pasteur Retinoic acid receptor and derivatives thereof, DNA encoding either substance and use of the proteins and of the DNA

Also Published As

Publication number Publication date
EP0471804B1 (fr) 2002-07-17
ES2181667T3 (es) 2003-03-01
US6103887A (en) 2000-08-15
FR2658204B1 (https=) 1994-08-19
ATE220717T1 (de) 2002-08-15
DE69133067D1 (de) 2002-08-22
WO1991012324A1 (fr) 1991-08-22
FR2658204A1 (fr) 1991-08-16
US5849508A (en) 1998-12-15
EP0471804A1 (fr) 1992-02-26

Similar Documents

Publication Publication Date Title
DE69233191T2 (de) Cyclin Prad1 (Cyclin D1) und seine cDNA
DE69315068T2 (de) Amplification von Humanen MDM2 Gen in Humanen Tumoren
DE69333043T2 (de) Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen
DE3587465T2 (de) Vielfache Drogen-Resistenz in Säugetierzellinien und Isolierung der determinanten Glykoprotein-DNS.
DE3888425T2 (de) Virale Expressionsinhibitoren.
EP1027440B1 (de) Inhibitor-protein des wnt-signalwegs
DE3588177T2 (de) Verfahren zur Feststellung der Anwesenheit eines selbstimmunen Antikörpers
DE69532767T2 (de) Peptid umfassend eine Sequenz aus einer Fusionsverbindungsstelle in einem mutierten EGF-Rezeptor vom Typ III
DE69325383T2 (de) Testreihenanalyse-Verfahren mit transkriptionsfaktor DP-1
DE69302234T2 (de) Menschliches Prohibitin und Prohibitin kodierende DNS
WO1992021766A1 (de) Monoklonale antikörper gegen c-kit
DE69229219T2 (de) Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin
EP0655926B1 (de) Neue sonde zur tumordiagnostik oder tumortherapie
DE69133067T2 (de) Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung
DE69232619T2 (de) Intestinale kleeblatt-proteine
DE9219038U1 (de) Immunotestsystem für lösliches lymphoides CD30-Antigen
EP0805204B1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
EP0440321B1 (de) Epididymis-spezifische Polypeptide und deren Verwendung
DE3884853T2 (de) Angiogenininhibitoren.
DE69513025T2 (de) Test für inhibitoren von dp-1 und anderen dp-proteinen
DE69433274T2 (de) Protein P53as sowie Plasmide und virale Vektoren, die eine zu der das Protein codierende DNA-Sequenz komplementäre cDNA-Sequence enthalten
DE69832447T2 (de) Gen kodierend für Afadin-1
DE69728436T9 (de) Leptin-protein aus schwein, dafür kodierende nukleinsäuren und verwendungen davon
DE69027967T2 (de) Proteine, die die expression von vertebraten-mhc-klasse-ii-genen regulieren, dafür kodierende dna-sequenzen und pharmazeutische zusammensetzungen
EP1237910B1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition